Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Feb 25.

Published in final edited form as: J Pharm Sci. 2011 May 26;100(9):3831–3842. doi: 10.1002/jps.22640

Uptake of propranolol 10μM, losartan 10μM, or eprosartan 10μM in (a) rat hepatocytes and (b) human hepatocytes in the presence of normal serum, hemodyalisis serum, rifampin 10μM, or CYP inhibitor. Average ± SD, *p<0.05, n=4.

Uptake of propranolol 10μM, losartan 10μM, or eprosartan 10μM in (a) rat hepatocytes and (b) human hepatocytes in the presence of normal serum, hemodyalisis serum, rifampin 10μM, or CYP inhibitor. Average ± SD, *p<0.05, n=4.